Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Impact of socioeconomic status on survival of colorectal cancer patients.

Zhang Q, Wang Y, Hu H, Huang R, Xie L, Liu E, Chen YG, Wang G, Wang X.

Oncotarget. 2017 Sep 13;8(62):106121-106131. doi: 10.18632/oncotarget.20859. eCollection 2017 Dec 1.

2.

Ethnic differences in colon cancer care in the Netherlands: a nationwide registry-based study.

Lamkaddem M, Elferink MAG, Seeleman MC, Dekker E, Punt CJA, Visser O, Essink-Bot ML.

BMC Cancer. 2017 May 4;17(1):312. doi: 10.1186/s12885-017-3241-5.

3.

Race/ethnicity and socio-economic differences in colorectal cancer surgery outcomes: analysis of the nationwide inpatient sample.

Akinyemiju T, Meng Q, Vin-Raviv N.

BMC Cancer. 2016 Sep 5;16:715. doi: 10.1186/s12885-016-2738-7.

4.

Adverse Clinical Outcome Associated With Mutations That Typify African American Colorectal Cancers.

Wang Z, Li L, Guda K, Chen Z, Barnholtz-Sloan J, Park YS, Markowitz SD, Willis J.

J Natl Cancer Inst. 2016 Aug 31;108(12). pii: djw164. doi: 10.1093/jnci/djw164. Print 2016 Dec.

5.

A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.

Govindarajan R, Posey J, Chao CY, Lu R, Jadhav T, Javed AY, Javed A, Mahmoud FA, Osarogiagbon RU, Manne U.

BMC Cancer. 2016 Jun 18;16:368. doi: 10.1186/s12885-016-2365-3.

6.

A meta-analysis of MSI frequency and race in colorectal cancer.

Ashktorab H, Ahuja S, Kannan L, Llor X, Ellis NA, Xicola RM, Laiyemo AO, Carethers JM, Brim H, Nouraie M.

Oncotarget. 2016 Apr 23;7(23):34546-57. doi: 10.18632/oncotarget.8945.

7.

Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.

Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H.

Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2.

8.

Differences in Colorectal Cancer Outcomes by Race and Insurance.

Tawk R, Abner A, Ashford A, Brown CP.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010048. doi: 10.3390/ijerph13010048.

9.

Integrating Equity in a Public Health Funding Strategy.

Joseph KT, Rice K, Li C.

J Public Health Manag Pract. 2016 Jan-Feb;22 Suppl 1:S68-76. doi: 10.1097/PHH.0000000000000346.

10.

The Relationship between Neighborhood Immigrant Composition, Limited English Proficiency, and Late-Stage Colorectal Cancer Diagnosis in California.

Mojica CM, Glenn BA, Chang C, Bastani R.

Biomed Res Int. 2015;2015:460181. doi: 10.1155/2015/460181. Epub 2015 Oct 4.

11.

Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centers.

Bhatt VR, Dhakal P, Dahal S, Giri S, Pathak R, Bociek RG, Silberstein PT, Armitage JO.

Ther Adv Hematol. 2015 Oct;6(5):223-7. doi: 10.1177/2040620715592568.

12.

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.

Yoon HH, Shi Q, Alberts SR, Goldberg RM, Thibodeau SN, Sargent DJ, Sinicrope FA; Alliance for Clinical Trials in Oncology.

J Natl Cancer Inst. 2015 Jul 9;107(10). pii: djv186. doi: 10.1093/jnci/djv186. Print 2015 Oct.

13.

Factors that influence minority use of high-volume hospitals for colorectal cancer care.

Huang LC, Tran TB, Ma Y, Ngo JV, Rhoads KF.

Dis Colon Rectum. 2015 May;58(5):526-32. doi: 10.1097/DCR.0000000000000353.

14.

Patient characteristics associated with the level of patient-reported care coordination among male patients with colorectal cancer in the Veterans Affairs health care system.

Jackson GL, Zullig LL, Phelan SM, Provenzale D, Griffin JM, Clauser SB, Haggstrom DA, Jindal RM, van Ryn M.

Cancer. 2015 Jul 1;121(13):2207-13. doi: 10.1002/cncr.29341. Epub 2015 Mar 17.

15.

Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.

Penn DC, Chang Y, Meyer AM, DeFilippo Mack C, Sanoff HK, Stitzenberg KB, Carpenter WR.

Cancer. 2015 Jan 1;121(1):93-101. doi: 10.1002/cncr.29028. Epub 2014 Sep 10.

16.

Individual- and neighborhood-level predictors of mortality in Florida colorectal cancer patients.

Tannenbaum SL, Hernandez M, Zheng DD, Sussman DA, Lee DJ.

PLoS One. 2014 Aug 29;9(8):e106322. doi: 10.1371/journal.pone.0106322. eCollection 2014.

17.

Colon cancer treatment: are there racial disparities in an equal-access healthcare system?

Gill AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K.

Dis Colon Rectum. 2014 Sep;57(9):1059-65. doi: 10.1097/DCR.0000000000000177.

18.

Hospital and geographic variability in two colorectal cancer surgery outcomes: complications and mortality after complications.

Schootman M, Lian M, Pruitt SL, Hendren S, Mutch M, Deshpande AD, Jeffe DB, Davidson NO.

Ann Surg Oncol. 2014 Aug;21(8):2659-66. doi: 10.1245/s10434-013-3472-x. Epub 2014 Apr 21.

19.

Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).

Sha D, Lee AM, Shi Q, Alberts SR, Sargent DJ, Sinicrope FA, Diasio RB.

Clin Cancer Res. 2014 Jun 15;20(12):3319-27. doi: 10.1158/1078-0432.CCR-14-0069. Epub 2014 Apr 11.

20.

Colorectal cancer in patients seen at the teaching hospitals of Guadeloupe and Martinique: discrepancies, similarities in clinicopathological features, and p53 status.

Decastel M, Ossondo M, Andrea AM, Tressieres B, Veronique-Baudin J, Deloumeaux J, Lubeth M, Smith-Ravin J.

BMC Clin Pathol. 2014 Mar 29;14(1):12. doi: 10.1186/1472-6890-14-12.

Supplemental Content

Support Center